Ask AI
ProCE Banner Series

Congress to Clinic: Clinical Advances Journal Club on Emerging CAR T-Cell Therapy Data from Summer Conferences ASCO, EHA, and ICML

Register for this interactive live webinar to learn about the latest data for CAR T-cell therapy from experts in lymphomas and multiple myeloma. 

  AMA
Who Should Attend

This educational activity is intended for hematologists, oncologists, and other healthcare professionals who treat patients with hematologic malignancies that may be candidates for CAR T-cell therapies.

All Events

Congress to Clinic: Clinical Advances Journal Club on Emerging CAR T-Cell Therapy Data from Summer Conferences ASCO, EHA, and ICML

Upcoming Events

August

22

2025

12:30 PM - 1:30 PM Eastern Time (ET)

Virtual

Topics

Hematologic malignancies
Lymphomas
Multiple myeloma

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to improve the learner's knowledge, confidence, and competence when considering CAR T-cell treatment strategies for patients with hematologic malignancies.

Target Audience
This educational activity is intended for hematologists, oncologists, and other healthcare professionals who treat patients with hematologic malignancies that may be candidates for CAR T-cell therapies.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Evaluate emerging data for novel CAR T-cell therapies and the potential implications for near-future clinical management of patients with hematologic malignancies

  • Plan optimal therapeutic approaches for patients with hematologic malignancies eligible for CAR T-cell therapies based on the latest clinical trial data

  • Apply the most recent real-world and clinical trial data for CAR T-cell therapies to mitigate toxicity risk and support quality of life for patients with hematologic malignancies

  • Determine if individual patients with hematologic malignancies are candidates for an ongoing investigational clinical trial with CAR T-cell therapies

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.com to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191